TY - JOUR
T1 - Mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: MissionEB protocol for a randomised, double-blinded, placebo-controlled, two-centre, crossover trial with an internal phase I dose de-escalation phase and open-label extension
JO - BMJ Open
UR - https://eprints.whiterose.ac.uk/id/eprint/227078
PY - 2025/05/21
AU - Bageta ML
AU - Lè´¸pez-Balboa P
AU - Dimairo M
AU - Glover R
AU - Hutchence K
AU - Papaioannou D
AU - Cooper C
AU - Biggs K
AU - Tappenden P
AU - Ennis K
AU - Ogboli M et al
ED -
DO - DOI: 10.1136/bmjopen-2024-089857
PB - BMJ
VL - 15
IS - 5
Y2 - 2025/07/15
ER -